These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24463484)

  • 21. Systemic treatment of advanced pancreatic cancer.
    Heinemann V; Haas M; Boeck S
    Cancer Treat Rev; 2012 Nov; 38(7):843-53. PubMed ID: 22226241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers.
    Montana M; Ducros C; Verhaeghe P; Terme T; Vanelle P; Rathelot P
    J Chemother; 2011 Apr; 23(2):59-66. PubMed ID: 21571619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
    Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel taxanes.
    Muggia F; Kudlowitz D
    Anticancer Drugs; 2014 May; 25(5):593-8. PubMed ID: 24374330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy evaluation of albumin-bound paclitaxel.
    Cecco S; Aliberti M; Baldo P; Giacomin E; Leone R
    Expert Opin Drug Saf; 2014 Apr; 13(4):511-20. PubMed ID: 24559090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The current status of docetaxel for metastatic breast cancer.
    Esteva FJ
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):17-26. PubMed ID: 12108894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug insight: Use of docetaxel in prostate and urothelial cancers.
    Mackler NJ; Pienta KJ
    Nat Clin Pract Urol; 2005 Feb; 2(2):92-100; quiz 1 p following 112. PubMed ID: 16474654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
    Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.
    Dang CT
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):427-36. PubMed ID: 16503859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.
    Ernsting MJ; Hoang B; Lohse I; Undzys E; Cao P; Do T; Gill B; Pintilie M; Hedley D; Li SD
    J Control Release; 2015 May; 206():122-30. PubMed ID: 25804872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer.
    Al-Hajeili M; Azmi AS; Choi M
    Onco Targets Ther; 2014; 7():187-92. PubMed ID: 24523592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced stage pancreatic cancer: novel therapeutic options.
    Saif MW
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):487-98. PubMed ID: 24939470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of taxanes on the management of genitourinary cancers.
    Balar AV
    Anticancer Drugs; 2014 May; 25(5):555-60. PubMed ID: 24525590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nab-paclitaxel for metastatic pancreatic cancer: clinical outcomes and potential mechanisms of action.
    Al-Batran SE; Geissler M; Seufferlein T; Oettle H
    Oncol Res Treat; 2014; 37(3):128-34. PubMed ID: 24685917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic cancer: systemic combination therapies for a heterogeneous disease.
    Melisi D; Calvetti L; Frizziero M; Tortora G
    Curr Pharm Des; 2014; 20(42):6660-9. PubMed ID: 25341938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macular Cystoid Edema Induced by Nab-Paclitaxel.
    Alves Pereira S; Vale C; Moreira J; Sampaio F
    Acta Med Port; 2022 Apr; 35(4):294-297. PubMed ID: 34287143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nursing Implications of Chemotherapy Agents and Their Associated Side Effects in Patients With Pancreatic Cancer.
    Hronek JW; Reed M
    Clin J Oncol Nurs; 2015 Dec; 19(6):751-7. PubMed ID: 26583639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of pancreatic cancer. Actuality and perspective].
    Bittoni A; Andrikou K; Lanese A; Santoni M; Pellei C; Faloppi L; Del Prete M; Giampieri R; Cascinu S
    Recenti Prog Med; 2015 May; 106(5):208-16. PubMed ID: 25994537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Horizons in the Treatment of Metastatic Pancreatic Cancer: A Review of the Key Biology Features and the Most Recent Advances to Treat Metastatic Pancreatic Cancer.
    Verdaguer H; Arroyo A; Macarulla T
    Target Oncol; 2018 Dec; 13(6):691-704. PubMed ID: 30470972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.